Pubblicazioni

ELENCO AGGIORNATO DELLE PUBBLICAZIONI DA PubMed (Dall’elenco devono essere sottratti i lavori di autori omonimi) ELENCO AGGIORNATO DELLE PUBBLICAZIONI E CITAZIONI RICAVATE DA Google Scholar

ELENCO DELLE 40 PUBBLICAZIONI PIÙ CITATE DA WEB of Science

  1. Multicenter standardized F-18-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. Mosconi, L; Tsui, WH.; Herholz, K; et al. Journal of Nuclear Medicine. Volume: 49 Issue: 3 Pages: 390-398
  2. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [F-18]FDG PET: a clinical validation of statistical parametric mapping. Signorini, M; Paulesu, E; Friston, K; et al. Neuroimage. Volume: 9 Issue: 1 Pages: 63-80
  3. Presurgical identification of hibernating myocardium by combined use of Tc-99m Hexakis 2-Methoxyisobutylisonitrile single photon-emission tomography and F-18 fluoro-2-deoxy-d-glucose positron emission tomography in patients with coronary-artery disease: Lucignani, G; Paolini, G; Landoni, C; et al. European Journal of Nuclear Medicine. Volume: 19 Issue: 10 Pages: 874-881
  4. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats: Porrino, LJ; Lucignani, G; Dow Edwards, D; et al. Brain Research. Volume: 307 Issue: 1-2 Pages: 311-320
  5. High-resolution Technetium-99m-HMPAO SPECT in patients with probable Alzheimers disease – comparison with fluorine-18-FDG PET: Messa, C; Perani, D; Lucignani, G; et al. Journal of Nuclear Medicine. Volume: 35 Issue: 2 Pages: 210-216
  6. Measurement of local cerebral blood-flow with [C-14] Iodoantipyrine in the mouse: Jay, TM; Lucignani, G; Crane, AM; et al. Journal of Cerebral Blood Flow and Metabolism. Volume: 8 Issue: 1 Pages: 121-129
  7. The lumped constant of the deoxyglucose method in hypoglycemia – effects of moderate hypoglycemia on local cerebral glucose-utilization in the rat. Suda, S; Shinohara, mM; Miyaoka, M; et al. Journal of Cerebral Blood Flow and Metabolism. Volume: 10 Issue: 4 Pages: 499-509
  8. Performance evaluation of the new whole-body PET/CT scanner: Discovery ST. Bettinardi, V; Danna, M; Savi, A et al. European Journal of Nuclear Medicine and Molecular Imaging. Volume: 31 Issue: 6 Pages: 867-881
  9. Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. La Rocca, E; Fiorina, P; Di Carlo, V et al. Kidney International. Volume: 60 Issue: 5 Pages: 1964-1971
  10. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective: Lucignani, G; Paganelli, G; Bombardieri, E. Nuclear Medicine Communications. Volume: 25 Issue: 7 Pages: 651-656
  11. Sentinel lymph node detection following the hysteroscopic peritumoural injection of Tc-99m-labelled albumin nanocolloid in endometrial cancer. Maccauro, M; Lucignani, G; Aliberti, G et al: European Journal of Nuclear Medicine and Molecular Imaging. Volume: 32 Issue: 5 Pages: 569-574
  12. 5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Messa, C; Colombo, C; Moresco, RM et al. Psychopharmacology. Volume: 167 Issue: 1 Pages: 72-78
  13. Regional cerebral metabolism of glucose in comatose and vegetative state patients. Tommasino, C; Grana, C; Lucignani, G et al. Journal of Neurosurgical Anesthesiology. Volume: 7 Issue: 2 Pages: 109-116
  14. Specificity and sensitivity of exercise-induced st segment elevation for detection of residual viability – comparison with fluorodeoxyglucose and positron emission tomography. Margonato, A; Chierchia, SL; Xuereb, RG et al. Journal of The American College of Cardiology. Volume: 25 Issue: 5 Pages: 1032-1038
  15. [F-18] FDG PET in fatal familial insomnia – the functional-effects of thalamic lesions. Perani, D; Cortelli, P; Lucignani, G et al. Neurology. Volume: 43 Issue: 12 Pages: 2565-2569
  16. Influence of plasma-glucose concentration on lumped constant of the deoxyglucose method – effects of hyperglycemia in the rat. Schuier, F; Orzi, F; Suda, S et al. Journal of Cerebral Blood Flow and Metabolism. Volume: 10 Issue: 6 Pages: 765-773
  17. Reexamination of glucose-6-phosphatase activity in the brain invivo – no evidence for a futile cycle. Nelson, T; Lucignani, G; Atlas, S et al. Science. Volume: 229 Issue: 4708 Pages: 60-62
  18. Measurement of regional cerebral glucose-utilization with fluorine-18-FDG and PET in heterogeneous tissues – theoretical considerations and practical procedure. Lucignani, G; Schmidt, KC; Moresco, RM et al. Journal of Nuclear Medicine. Volume: 34 Issue: 3 Pages: 360-369
  19. An automatic classification technique for attenuation correction in positron emission tomography. Bettinardi, V; Pagani, E; Gilardi, MC et al. European Journal of Nuclear Medicine. Volume: 26 Issue: 5 Pages: 447-458
  20. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose-utilization with current kinetic-models of the [F-18] fluorodeoxyglucose method. Schmidt, K; Lucignani, G; Moresco, RM et al. Journal of Cerebral Blood Flow and Metabolism. Volume: 12 Issue: 5 Pages: 823-834
  21. Brain single-photon emission tomography with Tc-99m-HMPAO in neuropsychiatric systemic lupus-erythematosus – relations with eeg and MRI findings and clinical manifestations. Colamussi, P; Giganti, M; Cittanti, C; et al. European Journal of Nuclear Medicine. Volume: 22 Issue: 1 Pages: 17-24
  22. FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients. Magnani, P; Carretta, A; Rizzo, G; et al. Journal of Cardiovascular Surgery. Volume: 40 Issue: 5 Pages: 741-748
  23. the use of spectral-analysis to determine regional cerebral glucose-utilization with positron emission tomography and [F-18] fluorodeoxyglucose – theory, implementation, and optimization procedures. Turkheimer, F; Moresco, Rm; Lucignani, G et al. Journal of Cerebral Blood Flow and Metabolism. Volume: 14 Issue: 3 Pages: 406-422
  24. Anatomical and biochemical investigation of primary brain tumours. Del Sole, A; Falini, A; Ravasi, L; et al. European Journal of Nuclear Medicine. Volume: 28 Issue: 12 Pages: 1851-1872
  25. Pre-targeted immunodetection in glioma patients – tumor-localization and single-photon emission tomography imaging of [Tc-99m]PNAO-biotin. Paganelli, G; Magnani, P; Zito, F et al. European Journal of Nuclear Medicine. Volume: 21 Issue: 4 Pages: 314-321
  26. Individual cerebral metabolic deficits in alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study. Del Sole, A; Clerici, F; Chiti, A; et al. European Journal of Nuclear Medicine and Molecular Imaging. Volume: 35 Issue: 7 Pages: 1357-1366
  27. Local cerebral glucose-utilization in controlled graded-levels of hyperglycemia in the conscious rat. Orzi, F; Lucignani, G; Dow Edwards, D et al. Journal of Cerebral Blood Flow and Metabolism. Volume: 8 Issue: 3 Pages: 346-356
  28. Effects of insulin on local cerebral glucose-utilization in the rat. Lucignani, G; Namba, H; Nehlig, A et al. Journal of Cerebral Blood Flow and Metabolism. Volume: 7 Issue: 3 Pages: 309-314
  29. Invalidity of criticisms of the deoxyglucose method based on alleged glucose-6-phosphatase activity in brain. Nelson, T; Lucignani, G; Goochee, J et al. Journal of Neurochemistry. Volume: 46 Issue: 3 Pages: 905-919
  30. Different patterns of local brain energy-metabolism associated with high and low-doses of methylphenidate – relevance to its action in hyperactive-children. Porrino, LJ; Lucignani, G Biological Psychiatry. Volume: 22 Issue: 2 Pages: 126-138
  31. Whole-body scintigraphy with Tc-99(m)-MIBI, F-18-FDG and I-131 in patients with metastatic thyroid carcinoma: Fridrich, L; Messa, C; Landoni, C et al. Nuclear Medicine Communications. Volume: 18 Issue: 1 Pages: 3-9
  32. Effects of insulin on hexose-transport across blood-brain-barrier in normoglycemia: Namba, H; Lucignani, G; Nehlig, A et al. American Journal of Physiology. Volume: 252 Issue: 3 Pages: E299-E303 Part: 1
  33. Remote effects of subcortical cerebrovascular lesions – a SPECT cerebral perfusion study: Perani, D; Di Piero, V; Lucignani, G; Journal of Cerebral Blood Flow and Metabolism. Volume: 8 Issue: 4 Pages: 560-567
  34. Gaba(A) receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [C-11]flumazenil: Lucignani, G; Panzacchi, A; Bosio, L; Neuroimage. Volume: 22 Issue: 1 Pages: 22-28
  35. Differential distribution of striatal [(123) I]Beta-CIT in Parkinson’s disease and progressive supranuclear palsy, evaluated with single-photon emission tomography: Messa, C; Volonte, MA; Fazio, F; European Journal of Nuclear Medicine. Volume: 25 Issue: 9 Pages: 1270-1276
  36. Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients: Fiorina, P; La Rocca, E; Astorri, E; Diabetes Care. Volume: 23 Issue: 12 Pages: 1804-1810
  37. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination: Schmidt, KC; Lucignani, G; Sokoloff, L. Journal of Nuclear Medicine. Volume: 37 Issue: 2 Pages: 394-399
  38. Metabolic and kinetic considerations in the use of [I-125] HIPDM for quantitative measurement of regional cerebral blood-flow: Lucignani, G; Nehlig, A; Blasberg, R; Journal of Cerebral Blood Flow and Metabolism. Volume: 5 Issue: 1 Pages: 86-96
  39. Molecular imaging: a new way to study molecular processes in vivo: Ottobrini, L; Ciana, P; Biserni, A. Conference: International Symposium On Steroid Hormone Receptor Superfamily and Molecular Signaling Location: Trivandrum, Indiadate: Nov 25-27, 2004 Molecular and Cellular Endocrinology. Volume: 246 Issue: 1-2 Pages: 69-75
  40. Effects of acute administration of caffeine on local cerebral glucose-utilization in the rat: Nehlig, A; Lucignani, G; Kadekaro, M; European Journal of Pharmacology. Volume: 101 Issue: 1-2 Pages: 91-100